Filter
482
Text search:
Pharmaceutical
Prices
Featured
Recommendations
39
New Publications
135
Language
Document type
No document type
239
Studies & Reports
132
Guidelines
50
Strategic & Response Plan
25
Manuals
17
Fact sheets
8
Situation Updates
6
Training Material
4
Resource Platforms
1
Countries / Regions
India
21
Global
21
Kenya
16
Uganda
14
Sierra Leone
9
Ghana
9
Ukraine
9
Liberia
8
Nigeria
8
Zambia
8
Tanzania
8
Ethiopia
7
Philippines
7
Syria
7
South Africa
7
Malawi
7
Zimbabwe
6
Nepal
6
Indonesia
6
Congo, Democratic Republic of
5
Bangladesh
5
Namibia
5
Western and Central Europe
5
Senegal
4
Cameroon
4
Rwanda
4
Botswana
4
Myanmar / Burma
4
Latin America and the Carribbean
4
Venezuela
4
Haiti
3
Mozambique
3
Lesotho
3
Africa
3
Eastern Europe
3
Pakistan
2
Germany
2
Papua New Guinea
2
Benin
2
Eswatini/ Swaziland
2
Albania
2
Burkina Faso
1
Mali
1
Niger
1
South Sudan
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
China
1
Sudan
1
Central African Republic
1
North Macedonia
1
Libya
1
Sri Lanka
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Mongolia
1
Southern Africa
1
Laos
1
Bulgaria
1
Lithuania
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
201
Clinical Guidelines
35
Public Health
17
Pharmacy & Technologies
13
Key Resources
12
Women & Child Health
9
Capacity Building
2
Toolboxes
Pharmacy
57
AMR
44
HIV
41
COVID-19
40
Mental Health
30
TB
14
Global Health Education
12
Health Financing Toolbox
12
Conflict
10
Planetary Health
8
NTDs
8
NCDs
7
Caregiver
5
Ebola & Marburg
4
Disability
3
Refugee
3
Polio
2
Malaria
2
Cholera
1
Natural Hazards
1
Rapid Response
1
2.0 Rapid Response
1
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Accessed: 26.11.2019
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac
...
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co
...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t
...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid,
...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi
...
